Patriot One Technologies Inc. (Nasdaq: PTOF)
PTOF is a Canadian company specialized in developing radar based technologies and systems for detecting concealed weapons preemptively combating public threats and domestic terrorism. What makes them unique is the cognitive ability of their tech to assess threats in addition to detecting guns and knives. This means the system is trained before installment and continues to learn increasing in effectiveness with each screen.
In the wake of the recent tragedies like the vegas shooter and countless school shootings products like this increasingly have a place in society. There stock is currently trading at $1.34 per share. If they succeed at winning over the plethora of potential public and private customers in the U.S and Canada and their tech becomes proven at preventing acts of terror they would become extremely profitable.
To learn more here is a link to a company presentation
MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates are not registered financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.
The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.